Skip to main content
Premium Trial:

Request an Annual Quote

Dharmacon to Supply siRNA Libraries to Cancer Research UK

NEW YORK, April 18 (GenomeWeb News) - RNAi reagent provider Dharmacon said today that it has signed a deal under which it will provide its siRNA libraries to Cancer Research UK for use in drug discovery and development.

 

According to Dharmacon, the libraries will initially include protein kinase genes and associated pathways. They will be used by Cancer Research UK scientists studying signal transduction, protein phosphorylation, secretory pathways, and biochemical regulatory mechanisms.

 

If this research is successful, Cancer Research UK intends to use larger siRNA libraries, Julian Downward, principal scientist at the Signal Transduction Laboratory at the research institute, said in a statement.

 

Specific terms of the arrangement were not disclosed.